Novanta Inc. (LON:0VAG)
| Market Cap | 3.49B |
| Revenue (ttm) | 716.09M |
| Net Income (ttm) | 39.39M |
| Shares Out | n/a |
| EPS (ttm) | 1.09 |
| PE Ratio | 88.69 |
| Forward PE | 32.98 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 867 |
| Average Volume | 143 |
| Open | 128.50 |
| Previous Close | 131.61 |
| Day's Range | 128.50 - 131.42 |
| 52-Week Range | 99.31 - 152.48 |
| Beta | 1.60 |
| RSI | 64.16 |
| Earnings Date | Feb 24, 2026 |
About Novanta
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision... [Read more]
Financial Performance
In 2024, Novanta's revenue was $949.25 million, an increase of 7.67% compared to the previous year's $881.66 million. Earnings were $64.09 million, a decrease of -12.06%.
Financial numbers in USD Financial StatementsNews
Notable Wednesday Option Activity: SWK, NOVT, NET
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Stanley Black & Decker Inc (Symbol: SWK), where a total volume of 7,143 contracts ...
NOVT Crosses Above Key Moving Average Level
In trading on Tuesday, shares of Novanta Inc (Symbol: NOVT) crossed above their 200 day moving average of $118.71, changing hands as high as $124.93 per share. Novanta Inc shares are currently trading...
Goldman Sachs Small/Mid Cap Growth Fund Q3 2025 Portfolio Update
The Goldman Sachs Small/Mid Cap Growth Fund-Institutional Shares underperformed its benchmark, the Russell 2500 Growth Index (net), during the quarter. We initiated a position in Planet Fitness, Inc. ...
Insider Sell: Thomas Secor Sells 747 Shares of Novanta Inc (NOVT)
Insider Sell: Thomas Secor Sells 747 Shares of Novanta Inc (NOVT)
Novanta to Present at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Chuck Ravetto, Chief...
Insider Selling: Thomas Secor Sells Shares of Novanta Inc (NOVT)
Insider Selling: Thomas Secor Sells Shares of Novanta Inc (NOVT)
Bullish Two Hundred Day Moving Average Cross - NOVT
In trading on Tuesday, shares of Novanta Inc (Symbol: NOVT) crossed above their 200 day moving average of $119.96, changing hands as high as $121.34 per share. Novanta Inc shares are currently trading...
Novanta to Present at the J.P. Morgan 44th Annual Healthcare Conference on Wednesday, January 14, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Ch...
Novanta Inc. (NOVT) Presents at Jefferies London Healthcare Conference 2025 - Slideshow
2025-11-17. The following slide deck was published by Novanta Inc.
5 Tech And Consumer Stocks At Risk Of Steep Declines
As the market grows increasingly top-heavy, the risks for fundamentally weaker and average-strength companies are increasing. The number of stocks losing momentum over the past year has mounted as meg...
Q3 2025 Novanta Inc Earnings Call Transcript
Q3 2025 Novanta Inc Earnings Call Transcript
Novanta Inc. Announces Pricing of $550,000,000 Tangible Equity Units Offering
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has ...
Vanguard Group Inc's Strategic Acquisition of Novanta Inc Shares
Vanguard Group Inc's Strategic Acquisition of Novanta Inc Shares
Novanta Inc. Announces Offering of Tangible Equity Units
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has ...
Novanta targets $400M advanced surgery revenue by 2030 as new product launches accelerate growth
Novanta Inc. (NOVT) Q3 2025 Earnings Call Transcript
Decoding Novanta Inc (NOVT): A Strategic SWOT Insight
Decoding Novanta Inc (NOVT): A Strategic SWOT Insight
Novanta Inc. (NOVT) Projects Fourth Quarter Revenue Growth
Novanta Inc. (NOVT) Projects Fourth Quarter Revenue Growth
Novanta Inc Q3 2025 Earnings: Revenue Surpasses Estimates at $247.8M, GAAP EPS Falls Short at $0.30
Novanta Inc Q3 2025 Earnings: Revenue Surpasses Estimates at $247.8M, GAAP EPS Falls Short at $0.30
Novanta Non-GAAP EPS of $0.87 beats by $0.05, revenue of $247.8M beats by $1.85M
Novanta Announces Financial Results for the Third Quarter 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial res...
Novanta to Present at Jefferies Global Healthcare Conference on Tuesday, November 18, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Ch...
Novanta (NOVT) Surges 8.3%: Is This an Indication of Further Gains?
Novanta (NOVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Growth Fund Sells $20 Million in Novanta Stock as Headwinds Weigh on Returns
Growth Fund Sells $20 Million in Novanta Stock as Headwinds Weigh on Returns